Pharmaceutical companies must worry less about squeezing additional profits from old medicines by copying the last successful drug and insisting on additional patent protections and focus more on new and innovative medicine.
The patent on a new drug starts running out the second the medicine is invented, and it can take many, many years to get these big clinical trials done.